We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
SpyBiotech, an Oxford University spinout developing a molecular superglue for rapid development of vaccines targeting a range of diseases, secures £4m seed funding at launch, led by Oxford Sciences Innovation with participation from GV.
Oxford Cancer Biomarker’s ColoTox test will now be available to UK patients considering chemotherapy.
Following research showing Oxford University has produced more founders of billion-dollar startups than any other institution in Europe, Oxford University Innovation’s Gregg Bayes-Brown takes a closer look at the founders, their ties to Oxford, and the companies they’ve launched.
Oxford University Innovation’s management consultancy division to restructure as separate entity to scale up interactions and business on the world stage.
Oxford spinout Celleron Therapeutics raises funding from South Korean consortium of investors for small molecule treatments.
OxSonics, an Oxford University spinout established in 2013 to develop ultrasound therapeutics, has secured £9.4m in series B equity financing, bringing its total external fundraising to £14.2m.
Oxford University Innovation launches 24 companies in 2016 with a combined £52.6m in early stage funding, setting a new record in spinout generation for the UK and Europe.
HTC Vive and virtual reality distance learning platform Engage to showcase the LIFE project from the University of Oxford.